Sanofi- Aventis (Paris, France) and Bristol- Myers Squibb (New York, NY) and Apotex, Inc. and Apotex Corporation (Toronto, Canada) announced that in response to concerns raised by the Federal Trade Commission ("FTC") and state attorneys general to the previously announced proposed settlement the companies reached with...
Business Editors/Health/Medical Writers WESTON, Fla.--BUSINESS WIRE--April 26, 2004 Apotex Corp. today praised the decision of the U.S. Court of Appeals for the Federal Circuit holding that GSK's U.S. Patent No. 4,721,723, the patent covering PaxilR paroxetine hydrochloride, is invalid. "We feel vindicated with this decision," said Apotex...
IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) announced today that the United States Court of Appeals for the Federal Circuit has affirmed a favorable ruling for Allergan and Roche Palo Alto, LLC, formerly known as Syntex (U.S.A.) LLC, in a patent infringement lawsuit against Apotex, Inc., Apotex Corp., and Novex Pharma...
The FDA has asked for more time to respond to a 2/00 Apotex petition that asked the agency to admit improper listing of two new SmithKline Beecham patents on Paxil paroxerine, Apotex lead attorney Hugh Moore (Lord, Bissell & Brook, Chicago) told Dickinson's FDA Webview (www.fdaweb.com) in August. Apotex sued...
WESTON, Fla. -- Apotex Inc. and Apotex Corp. announced today that they have reached an agreement with Sanofi-aventis and Bristol-Myers Squibb, subject to certain conditions, to settle the patent infringement lawsuit pending between the parties in the U.S. District Court for the Southern District of New York. The lawsuit relates...
SANOFI -Synthelabo Inc. has filed a complaint in a federal district court against Apotex Inc. and Apotex Corp. alleging patent infringement over Plavix clopidogrel bisulfate. UBS Warburg predicts litigation resolution by mid-2004. UBS Warburg estimates globally developed sales with marketing partner Bristol-Myers Squibb Company for Plavix...
CINCINNATI -- Kroger Co. has gone to court to block a deal that would delay generic alternatives to the popular blood-thinning drug Plavix. Bristol-Myers Squibb Co. and Sanofi-Aventis had reached a settlement with generic drug maker Apotex Inc. over a patent dispute regarding Plavix, which is the world's No....
IN A GENERICS battle in the antidepressant market, Apotex Corp. is seeking an injunction against GlaxoSmithKline GSK and the Food and Drug Administration FDA over its bid to launch a generic version of Paxil paroxetine, GSK's top-selling anti IN A GENERICS battle in the...
PARIS AFP — French pharmaceutical group Sanofi-Aventis has slashed its 2006 earnings per share forecast from 12 percent to just two percent due to competition for its blockbuster blood-thinner Plavix from a generic drug. The revision came a day after a New York court granted the company and its US...
NEW YORK AFP — A US judge on Tuesday upheld the patent for Plavix by French group Sanofi-Aventis and its US partner Bristol-Myers Squibb, blocking a generic version of the blockbuster heart drug. The ruling by US District Judge Sidney Stein bars Canadian firm Apotex from producing a generic...
CHICAGO -- Fitch Ratings places Bristol-Myers Squibb's (Bristol-Myers) 'A+' issuer default, senior unsecured debt, and bank loan ratings, and 'F1' commercial paper rating on Rating Watch Negative. The ratings apply to approximately $8.43 billion of outstanding debt. The rating action follows Apotex Inc.'s Apotex announcement of its launch of a...
IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) announced today that on December 29, 2005, in its patent infringement lawsuit against Apotex, Inc., Apotex Corp., and Novex Pharma (collectively the "Defendants"), the United District Court for the Northern District of California granted Allergan's and Syntex USA LLC's application for a temporary restraining...
Appeals Court Reverses Decision in Ofloxacin Patent Case CHICAGO -- The U.S. Court of Appeals for the Federal Circuit issued a decision on July 11, 2007 that Daiichi Sankyo Co.'s patent (U.S. Patent No. 5,401,741) covering a method for treating bacterial ear infections by topically administering the antibiotic ofloxacin...
Pfizer Wins Norvasc Patent Challenge by Generic Manufacturer Apotex NEW YORK, Jan. 18 -- Pfizer Inc said today that a federal court in the Northern District of Illinois Chicago has upheld the company's U.S. patent covering amlodipine bes ...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c60858) has announced the addition of Canada Pharmaceutical Industry to their offering.
NEW YORK -- Pfizer Inc said today it will appeal a Canadian Federal Court decision in favor of generic manufacturer Apotex in its challenge to a Pfizer patent covering Lipitor.
A Canadian company's cheap generic version of the blood thinner Plavix has been blocked from the U.S. market until at least 2011. U.S. District Judge Sidney H. Stein said Tuesday that Apotex Inc. had failed to prove during a three-week trial in New York City earlier this year that the...
* Generic drug companies wishing to use innovator companies' discontinued labeling as a way around those innovators' exclusivity-protected and revised labeling would be defeated if Johnson & Johnson gets its way. The company wrote the FDA in January objecting to a petition from Apotex that seeks the agency's approval to...
